Farmacie pro praxi. 2023;19(3):151-157

Diabetes monitoring for pharmacists

Robert Bém
Centrum diabetologie, Institut klinické a experimentální medicíny, Praha

Glucose determination is essential for the diagnosis and treatment of diabetes. In addition to laboratory blood glucose testing, there is currently a variety of options available for monitoring glucose levels, especially in the patient's home environment. These options include the use of glucometers and intermittent or continuous monitoring using sensors. Patients thus have the opportunity to perform highly effective self-monitoring and actively participate in diabetes management. According to Czech and international recommendations, glucose sensors are currently indicated for all individuals with type 1 diabetes. Insulin pumps are further indicated for a specific group, and when combined with sensors and algorithms - known as hybrid pumps - they lead to further improvement in glucose control. All of these technologies are available in the Czech Republic, commonly utilized, and covered by public healthcare funding.

Keywords: diabetes mellitus, glycemia, continuous glucose monitoring, glucose sensors.

Accepted: September 21, 2023; Published: October 2, 2023  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Bém R. Diabetes monitoring for pharmacists. Pharmacy for Practice. 2023;19(3):151-157.
Download citation

References

  1. Wright EE, Subramanian S. Evolving Use of Continuous Glucose Monitoring Beyond Intensive Insulin Treatment. Diabetes Technol Ther. 2021;23(S3):S12-S8. Go to original source... Go to PubMed...
  2. Battelino T, Alexander CM, Amiel SA, Arreaza­‑Rubin G, Beck RW, Bergenstal RM, et al. Continuous glucose monitoring and metrics for clinical trials: an international consensus statement. Lancet Diabetes Endocrinol. 2023;11(1):42-57. Go to original source... Go to PubMed...
  3. Evidence reviews for continuous glucose monitoring in adults with type 1 diabetes: Type 1 diabetes in adults: diagnosis and management: Evidence review B. London: National Institute for Health and Care Excellence (NICE); 2022
  4. Olczuk D, Priefer R. A history of continuous glucose monitors (CGMs) in self­‑monitoring of diabetes mellitus. Diabetes Metab Syndr. 2018;12(2):181-7. Go to original source... Go to PubMed...
  5. Ahmadian N, Manickavasagan A, Ali A. Comparative assessment of blood glucose monitoring techniques: a review. J Med Eng Technol. 2023;47(2):121-30. Go to original source... Go to PubMed...
  6. Sachmechi I, Salam S, Amini M, Khan R, Spitznogle A, Belen T. Frequent Monitoring of Blood Glucose Levels via a Remote Patient Monitoring System Helps Improve Glycemic Control. Endocr Pract. 2023. Go to original source...
  7. Speight J, Choudhary P, Wilmot EG, Hendrieckx C, Forde H, Cheung WY, et al. Impact of glycaemic technologies on quality of life and related outcomes in adults with type 1 diabetes: A narrative review. Diabet Med. 2023;40(1):e14944. Go to original source... Go to PubMed...
  8. Oriot P, Hermans MP. Intermittent­‑scanned continuous glucose monitoring with low glucose alarms decreases hypoglycemia incidence in middle­‑aged adults with type 1 diabetes in real­‑life setting. J Diabetes Complications. 2023;37(2):108385. Go to original source... Go to PubMed...
  9. Kluemper JR, Smith A, Wobeter B. Diabetes: the role of continuous glucose monitoring. Drugs Context. 2022;11. Go to original source... Go to PubMed...
  10. Sherr JL, Heinemann L, Fleming GA, Bergenstal RM, Bruttomesso D, Hanaire H, et al. Automated Insulin Delivery: Benefits, Challenges, and Recommendations. A Consensus Report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association. Diabetes Care. 2022;45(12):3058-74. Go to original source... Go to PubMed...
  11. Ascaso FJ, Huerva V. Noninvasive Continuous Monitoring of Tear Glucose Using Glucose­‑Sensing Contact Lenses. Optom Vis Sci. 2016;93(4):426-34. Go to original source... Go to PubMed...
  12. Flekač M. Time in range: new parameter to evaluate blood glucose control. Vnitř. Lék. 2022; 68(5):315-323. Go to original source... Go to PubMed...




Pharmacy for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.